Nova Patents
AU9463501A

Novel human protease inhibitor proteins and polynucleotides encoding the same

Abstract

Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

80 members in 8 offices

This recordMember, by publication datePriority claim

Priority claims6

Priority claims
DocumentOfficeKindDate
23410000United States of AmericaP
0129659United States of AmericaW
60234100–––
PCTUS0129659–––
US20000234100P–––
WO2001US29659–––

Members80

Family members, oldest first
DocumentOfficeKind
CA2386767A1CanadaA1
WO0121651A2World Intellectual Property Organization (WIPO)A2
CA2387231A1CanadaA1
WO0127273A1World Intellectual Property Organization (WIPO)A1
AU7876700AAustraliaA
AU7831100AAustraliaA
CA2387810A1CanadaA1
WO0129084A2World Intellectual Property Organization (WIPO)A2
AU1571701AAustraliaA
WO0136469A2World Intellectual Property Organization (WIPO)A2
AU1920601AAustraliaA
CA2399297A1CanadaA1
WO0158105A1World Intellectual Property Organization (WIPO)A1
WO0129084A3World Intellectual Property Organization (WIPO)A3
WO0136469A3World Intellectual Property Organization (WIPO)A3
WO0121651A3World Intellectual Property Organization (WIPO)A3
US2002034267A1United States of AmericaA1
WO0224894A2World Intellectual Property Organization (WIPO)A2
AU9463501AThis recordAustraliaA
WO0226981A2World Intellectual Property Organization (WIPO)A2
AU9308401AAustraliaA
US2002054632A1United States of AmericaA1
CA2429519A1CanadaA1
WO0250278A2World Intellectual Property Organization (WIPO)A2
AU4517002AAustraliaA
EP1226170A2European Patent Office (EPO)A2
US2002107382A1United States of AmericaA1
EP1232259A1European Patent Office (EPO)A1
US2002115204A1United States of AmericaA1
US6477210B2United States of AmericaB2
EP1256222A1European Patent Office (EPO)A1
WO03004609A2World Intellectual Property Organization (WIPO)A2
AU2002318186A1AustraliaA1
WO0224894A3World Intellectual Property Organization (WIPO)A3
US2003028907A1United States of AmericaA1
CA2457298A1CanadaA1
WO03016481A2World Intellectual Property Organization (WIPO)A2
JP2003511073AJapanA
US2003077820A1United States of AmericaA1
WO0226981A3World Intellectual Property Organization (WIPO)A3
WO0250278A3World Intellectual Property Organization (WIPO)A3
US2003166883A1United States of AmericaA1
JP2003528581AJapanA
EP1349932A2European Patent Office (EPO)A2
WO03016481A3World Intellectual Property Organization (WIPO)A3
JP2004500045AJapanA
EP1425382A2European Patent Office (EPO)A2
US6790660B1United States of AmericaB1
EP1425382A4European Patent Office (EPO)A4
US2004203110A1United States of AmericaA1
JP2004535154AJapanA
WO03004609A3World Intellectual Property Organization (WIPO)A3
JP2005500060AJapanA
US6852840B2United States of AmericaB2
WO0224894A9World Intellectual Property Organization (WIPO)A9
US6867291B1United States of AmericaB1
US2005059816A1United States of AmericaA1
US2005069919A1United States of AmericaA1
US2005089892A1United States of AmericaA1
US2005118626A1United States of AmericaA1
US2005164277A1United States of AmericaA1
US2005170384A1United States of AmericaA1
US2005227343A1United States of AmericaA1
CA2399297CCanadaC
AU783897B2AustraliaB2
AU784052B2AustraliaB2
US2006014277A1United States of AmericaA1
US2006029168A1United States of AmericaA1
EP1633872A2European Patent Office (EPO)A2
US2006122380A1United States of AmericaA1
US7099413B2United States of AmericaB2
US2008044896A1United States of AmericaA1
EP1226170B1European Patent Office (EPO)B1
AT402953TAustriaT
DE60039708D1GermanyD1
US7460620B2United States of AmericaB2
US2009080575A1United States of AmericaA1
EP1256222B1European Patent Office (EPO)B1
DE60139603D1GermanyD1
US7940852B2United States of AmericaB2